The effect of coenzyme Q10 on sudden sensorineural hearing loss treatment
Phase 3
Recruiting
- Conditions
- sudden sensorineural hearing loss.Sensorineural hearing loss, bilateralH90.3
- Registration Number
- IRCT20151123025202N23
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Unilateral Sudden sensorineural hearing loss
Age 18-70 Years
Less than one month has passed since the onset of symptoms
Exclusion Criteria
History of other ear diseases
Presence of a mass or other pathology on ear MRI
Conductive hearing loss
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in PTA and SRT auditory parameters. Timepoint: 3 and 6 months after starting treatment. Method of measurement: Through audiometry and audiogram parameters.
- Secondary Outcome Measures
Name Time Method Hearing-related quality of life. Timepoint: 3 and 6 months after starting treatment. Method of measurement: By asking a question: Over the past week, how much has the problem of hearing loss and deafness affected your quality of life in communicating with friends, family and colleagues? And responses on the Likert scale will range from very low to very high.